Study Endpoints
The study’s primary endpoints were the successful deployment of the
device and pacing capture in AV sequential synchrony. Safety endpoints
included major adverse cardiac events, any cardiac arrhythmia requiring
cardioversion, and pericardial effusion with or without associated
cardiac tamponade.